Frequencies of circulating allergen‐specific T cells temporally associate with longitudinal changes in severity of cutaneous atopic disease

Increased levels of allergen‐specific T‐cells have been documented in the peripheral blood of patients with atopic dermatitis (AD) compared with nonatopic controls. However, little is known about how these relate to disease severity. This study sought to examine if frequencies of circulating allergen‐specific T cells correlate with changes in clinical disease severity in a cohort of seven adults with AD who were positive for human leucocyte antigen DRB1*1501. We found that frequencies of allergen‐specific CD4+ T cells across the study group were not significantly (P > 0.05) associated with clinical disease severity; however, longitudinal changes within an individual did correlate significantly (P < 0.01) with changes in disease severity. These findings support a role for allergen‐specific T‐cells in disease pathogenesis.

[1]  G. Ogg,et al.  Role of T cells in the pathogenesis of atopic dermatitis , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  H. Williams,et al.  What are the best outcome measurements for atopic eczema? A systematic review. , 2007, The Journal of allergy and clinical immunology.

[3]  G. Ogg,et al.  Dose‐related reduction in allergen‐specific T cells associates with clinical response of atopic dermatitis to methotrexate , 2007, The British journal of dermatology.

[4]  G. Ogg,et al.  Bacterial superantigen facilitates epithelial presentation of allergen to T helper 2 cells , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Ogg,et al.  Persistent central memory phenotype of circulating Fel d 1 peptide/DRB1*0101 tetramer-binding CD4+ T cells. , 2006, The Journal of allergy and clinical immunology.

[6]  W. Cookson,et al.  The genetics of atopic dermatitis. , 2006, The Journal of allergy and clinical immunology.

[7]  Colin N A Palmer,et al.  Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis , 2006, Nature Genetics.

[8]  G. Abecasis,et al.  Association between quantitative traits underlying asthma and the HLA-DRB1 locus in a family-based population sample , 2001, European Journal of Human Genetics.

[9]  P. Burney,et al.  Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting , 1996, The British journal of dermatology.

[10]  I I Lelis,et al.  [Atopic dermatitis]. , 1980, Vestnik dermatologii i venerologii.